Pharmaceutical composition containing antifungal agent as active ingredient
关于老挝专利「Pharmaceutical composition containing antifungal agent as active ingredient」，老商通整理了如下公开信息，由 SATO PHARMACEUTICAL CO., LTD. 于 2020-08-07 提交申请，当前状态为等待形式审查。公开档案中可核验：申请号 P/824，DIP 编号 LAP824，主管局代码 LA，保护类型 Patent - PCT National Phase。时间线要点：公开/公告日 2026-02-27。国际分类 / IPC 标注为 A61K 31/10、A61K 31/4178、A61K 47/08、A61K 47/10、A61K 47/12、A61K 47/14、A61K 47/22、A61K 47/32。发明人 / 设计人包括 Kiyotaka MARSUL、Masahiro ITO、Masami INUMA。代理机构 / 代理人记载为 Lao Trademark Agency。公开摘要提示：The present invention provides a technique of allowing this pharmaceutical composition that contains luliconazole or the like and that is p…。
The following summary describes a Laos patent titled “Pharmaceutical composition containing antifungal agent as active ingredient”, filed by SATO PHARMACEUTICAL CO., LTD. on 2020-08-07; current status: Awaiting formal examination. Identifiers include application No. P/824; DIP id LAP824; protection kind Patent - PCT National Phase. Key dates: publication 2026-02-27. Classification: A61K 31/10、A61K 31/4178、A61K 47/08、A61K 47/10、A61K 47/12、A61K 47/14、A61K 47/22、A61K 47/32. Inventor(s)/designer(s): Kiyotaka MARSUL, Masahiro ITO, Masami INUMA. Abstract hint: The present invention provides a technique of allowing this pharmaceutical composition that contains luliconazole or the like and that is p…. Unique application identifiers, holders and classification text are surfaced here to reduce near-duplicate IP landing pages; always verify against the competent office.
ກ່ຽວກັບ ສິດທິບັດ «Pharmaceutical composition containing antifungal agent as active ingredient» ໃນລາວ, ຍື່ນໂດຍ SATO PHARMACEUTICAL CO., LTD. ໃນວັນທີ 2020-08-07; ສະຖານະ ລໍຖ້າກວດຮູບແບບ. ຕົວລະບຸ: ເລກທີຄຳຮ້ອງ P/824; ລະຫັດ DIP LAP824; ປະເພດການປົກປ້ອງ Patent - PCT National Phase. ວັນທີສຳຄັນ: ວັນເຜີຍແຜ່ 2026-02-27. ປະເພດ/ຫ້ອງ: A61K 31/10、A61K 31/4178、A61K 47/08、A61K 47/10、A61K 47/12、A61K 47/14、A61K 47/22、A61K 47/32. ນັກປະດິດ/ນັກອອກແບບ: Kiyotaka MARSUL, Masahiro ITO, Masami INUMA. ສະຫຼຸບ: The present invention provides a technique that allows a pharmaceutical composition, preferably. ຂໍ້ຄວາມນີ້ເນັ້ນຕົວເລກ, ວັນທີ, ປະເພດ ແລະ ຜູ້ຍື່ນ ເພື່ອຫຼຸດຄວາມຄ້າຍຄືນລະຫວ່າງໜ້າ IP; ກວດຂໍ້ມູນທາງການກ່ອນຕັດສິນໃຈ.
P/824
图样
基础信息
- 类型
- 专利
- 申请号
P/824- 状态
- 等待形式审查
- 申请人
- SATO PHARMACEUTICAL CO., LTD.
- 代理机构
- Lao Trademark Agency
- 申请日期
- 2020-08-07
- 公开/公告日
- 2026-02-27
- 国际分类
- A61K 31/10 · A61K 31/4178 · A61K 47/08 · A61K 47/10 · A61K 47/12 · A61K 47/14 · A61K 47/22 · A61K 47/32 · A61K 47/34
- 商品 / 服务
- —
办理流程
根据当前状态动态标注-
提交申请
-
形式审查 进行中
-
实质审查
-
公开
-
授权
关联分析
LaoBiz 企业数据库联动类似专利推荐
摘要
The present invention provides a technique that allows a pharmaceutical composition, preferably
for extemal use, containing luliconazole or the like to contain luliconazole or the like at a high concentration, and suppresses the precipitation thereof over time. The present invention uses a polyethylene glycol having an average molecular weight of 380 to 420 represented by a formula HOCHz(CHzOCHz).CHzOH (where n is an integer), ethanol, benzyl alcohol, lactic acid, propylene carbonate, and acetone in combination with the luliconazole or the like.
The present invention provides a technique of allowing this pharmaceutical composition that contains luliconazole or the like and that is preferably for topical use, to contain luliconazole or the like at a high concentration and to inhibit precipitation of the same over time. The present invention uses, in combination, a polyethylene glycol represented by formula HOCH